Elevated Plasma Angiopoietin-2 Levels and Primary Graft Dysfunction after Lung Transplantation

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Diamond, Joshua M ^a   Porteous, Mary K ^a   Cantu, Edward ^a   Meyer, Nuala J ^a   Shah, Rupal J ^a   Lederer, David J ^b   Kawut, Steven M ^a   Lee, James ^a   Bellamy, Scarlett L ^a   Palmer, Scott M ^c   Lama, Vibha N ^d   Bhorade, Sangeeta M ^e   Crespo, Maria ^f   Demissie, Ejigayehu ^a   Wille, Keith ^g   Orens, Jonathan ^h   Shah, Pali D ^h   Weinacker, Ann ⁱ   Weill, David ⁱ   Arcasoy, Selim ^b   Wilkes, David S ^j   Ware, Lorraine B ^k   Christie, Jason D ^a   more..

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b University of Pennsylvania School of Medicine ^*  (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g University of Alabama at Birmingham   (United States)

^h JOHNS HOPKINS HOSPITAL   (United States)

ⁱ STANFORD UNIVERSITY   (United States)

^j INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k VANDERBILT UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2;

ADULT; ARTICLE; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FIBROSING ALVEOLITIS; HUMAN; LUNG TRANSPLANTATION; MALE; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIMARY GRAFT DYSFUNCTION; PROTEIN BLOOD LEVEL; REPERFUSION;

ANGIOPOIETIN-2; CASE-CONTROL STUDIES; FEMALE; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PRIMARY GRAFT DYSFUNCTION; TIME FACTORS;

EID: 84871277703     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051932     Document Type: Article

References (36)

1. Arcasoy SM, Fisher A, Hachem RR, Scavuzzo M, Ware LB, (2005) Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part V: predictors and outcomes. J Heart Lung Transplant 24: 1483-8.
2. Christie JD, Bavaria JE, Palevsky HI, Litzky L, Blumenthal N, et al. (1998) Primary Graft Failure Following Lung Transplantation. Chest 114: 51-60.
3. Christie JD, Kotloff RM, Ahya VN, Tino G, Pochettino A, et al. (2005) The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 171: 1312-6.
4. Christie JD, Kotloff RM, Pochettino A, Arcasoy SM, Rosengard BR, et al. (2003) Clinical risk factors for primary graft failure following lung transplantation. Chest 124: 1232-41.
5. Diamond JM, Kawut SM, Lederer DJ, Ahya VN, Kohl B, et al. (2011) Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction. Am J Transplant 11: 561-7.
6. Diamond JM, Lederer DJ, Kawut SM, Lee J, Ahya VN, et al. (2011) Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis. Am J Transplant 11: 2517-22.
7. Lederer DJ, Kawut SM, Wickersham N, Winterbottom C, Bhorade S, et al. (2011) Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study. Am J Respir Crit Care Med 184: 1055-61.
8. Lee JC, Christie JD, (2009) Primary graft dysfunction. Proc Am Thorac Soc 6: 39-46.
9. Diamond JM, Christie JD, (2010) The contribution of airway and lung tissue ischemia to primary graft dysfunction. Curr Opin Organ Transplant 15: 552-7.
10. Krenn K, Klepetko W, Taghavi S, Lang G, Schneider B, et al. (2007) Recipient vascular endothelial growth factor serum levels predict primary lung graft dysfunction. Am J Transplant 7: 700-6.
11. Salama M, Andrukhova O, Hoda MA, Taghavi S, Jaksch P, et al. (2010) Concomitant endothelin-1 overexpression in lung transplant donors and recipients predicts primary graft dysfunction. Am J Transplant 10: 628-36.
12. Taghavi S, Abraham D, Riml P, Paulus P, Schafer R, et al. (2002) Co-expression of endothelin-1 and vascular endothelial growth factor mediates increased vascular permeability in lung grafts before reperfusion. J Heart Lung Transplant 21: 600-3.
13. Lee WL, Liles WC, (2011) Endothelial activation, dysfunction and permeability during severe infections. Curr Opin Hematol 18: 191-6.
14. Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, et al. (2006) Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 12: 235-9.
15. Gallagher DC, Parikh SM, Balonov K, Miller A, Gautam S, et al. (2008) Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome. Shock 29: 656-61.
16. Meyer NJ, Li M, Feng R, Bradfield J, Gallop R, et al. (2011) ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio. Am J Respir Crit Care Med 183: 1344-53.
17. Minhas N, Xue M, Fukudome K, Jackson CJ, (2010) Activated protein C utilizes the angiopoietin/Tie2 axis to promote endothelial barrier function. FASEB J 24: 873-81.
18. Bhandari V, Choo-Wing R, Lee CG, Zhu Z, Nedrelow JH, et al. (2006) Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med 12: 1286-93.
19. Giuliano JS Jr, Lahni PM, Harmon K, Wong HR, Doughty LA, et al. (2007) Admission angiopoietin levels in children with septic shock. Shock28: 650-4.
20. Orfanos SE, Kotanidou A, Glynos C, Athanasiou C, Tsigkos S, et al. (2007) Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med35: 199-206.
21. Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, et al. (2006) Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med3: e46.
22. Christie JD, Carby M, Bag R, Corris P, Hertz M, et al. (2005) Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 24: 1454-9.
23. Maldonado G, Greenland S, (1993) Simulation study of confounder-selection strategies. Am J Epidemiol 138: 923-36.
24. Fremont RD, Koyama T, Calfee CS, Wu W, Dossett LA, et al. (2010) Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis. J Trauma 68: 1121-7.
25. Fang X, Neyrinck AP, Matthay MA, Lee JW, (2010) Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1. J Biol Chem 285: 26211-22.
26. Mei SH, McCarter SD, Deng Y, Parker CH, Liles WC, et al. (2007) Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med4: e269.
27. Krenn K, Klepetko W, Taghavi S, Paulus P, Aharinejad S, (2007) Vascular endothelial growth factor increases pulmonary vascular permeability in cystic fibrosis patients undergoing lung transplantation. Eur J Cardiothorac Surg32: 35-41.
28. Aeba R, Griffith BP, Kormos RL, Armitage JM, Gasior TA, et al. (1994) Effect of cardiopulmonary bypass on early graft dysfunction in clinical lung transplantation. Ann Thorac Surg57: 715-22.
29. Gammie JS, Cheul Lee J, Pham SM, Keenan RJ, Weyant RJ, et al. (1998) Cardiopulmonary bypass is associated with early allograft dysfunction but not death after double-lung transplantation. J Thorac Cardiovasc Surg115: 990-7.
30. Kuntz CL, Hadjiliadis D, Ahya VN, Kotloff RM, Pochettino A, et al. (2009) Risk factors for early primary graft dysfunction after lung transplantation: a registry study. Clin Transplant 23: 819-30.
31. Brudney CS, Gosling P, Manji M, (2005) Pulmonary and renal function following cardiopulmonary bypass is associated with systemic capillary leak. J Cardiothorac Vasc Anesth 19: 188-92.
32. Giuliano JS Jr, Lahni PM, Bigham MT, Manning PB, Nelson DP, et al. (2008) Plasma angiopoietin-2 levels increase in children following cardiopulmonary bypass. Intensive Care Med 34: 1851-7.
33. Kumpers P, Nickel N, Lukasz A, Golpon H, Westerkamp V, et al. (2010) Circulating angiopoietins in idiopathic pulmonary arterial hypertension. Eur Heart J 31: 2291-300.
34. Margaritopoulos GA, Antoniou KM, Karagiannis K, Vassalou E, et al. (2010) Investigation of angiogenetic axis Angiopoietin-1 and-2/Tie-2 in fibrotic lung diseases: a bronchoalveolar lavage study. Int J Mol Med. 26: 919-23.
35. Christie JD, Bellamy S, Ware LB, Lederer DJ, Hadjiliadis D, et al. (2010) Construct validity of the definition of primary graft dysfunction after lung transplantation. J Heart Lung Transplant 29: 1231-9.
36. Ong T, McClintock DE, Kallet RH, Ware LB, Matthay MA, et al. (2010) Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients. Crit Care Med 38: 1845-51.